Silex Systems Limited (AU:SLX)
ASX:SLX
Top Page
Silex Systems Limited
(Sydney:SLX)
Select Model
Select Model
Rating:41Neutral
Price Target:
AU$5.00
▼(-5.48% Downside)
Action:ReiteratedDate:01/07/26
The score is primarily held down by weak financial performance (sharp revenue contraction, ongoing losses, and declining free cash flow). Technical signals also remain bearish with the price below key moving averages and a negative MACD, while valuation is constrained by loss-making results (negative P/E) and no dividend data.
Positive Factors
Low leverage / conservative balance sheet
A low debt-to-equity profile gives Silex financial flexibility to fund R&D, sustain operations, or absorb shocks without high interest burdens. For a capital-sensitive semiconductor business this reduces bankruptcy risk and preserves strategic optionality over multiple quarters.
Negative Factors
Significant revenue contraction
A sharp ~44% revenue decline signals weakening market traction or lost customers, which is difficult to reverse quickly in semiconductors where customer cycles and qualification times are long. Lower top-line makes sustaining R&D and commercial investments harder and raises execution risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / conservative balance sheet
A low debt-to-equity profile gives Silex financial flexibility to fund R&D, sustain operations, or absorb shocks without high interest burdens. For a capital-sensitive semiconductor business this reduces bankruptcy risk and preserves strategic optionality over multiple quarters.
Read all positive factors
Silex Systems Limited (SLX) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$1.48B
Dividend YieldN/A
Average Volume (3M)1.33M
Price to Earnings (P/E)―
Beta (1Y)2.56
Revenue Growth5.81%
EPS Growth-86.09%
CountryAU
Employees38
SectorTechnology
Sector Strength88
IndustrySemiconductors
Share Statistics
EPS (TTM)-0.07
Shares Outstanding278,302,730
10 Day Avg. Volume2,253,236
30 Day Avg. Volume1,326,806
Financial Highlights & Ratios
PEG Ratio-0.27
Price to Book (P/B)11.02
Price to Sales (P/S)147.55
P/FCF Ratio350.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$11.64Price Target Upside120.04% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.08
Revenue Forecast (FY)AU$7.42M
Silex Systems Limited Business Overview & Revenue Model
Company Description
Silex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser uranium enrichment technology in Australia. It operates through three segments: Silex Systems, Tr...
How the Company Makes Money
null...
Silex Systems Limited Financial Statement Overview
Summary
Income Statement
30
Negative
Balance Sheet
45
Neutral
Cash Flow
40
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.72M | 6.79M | 6.11M | 6.84M | 4.22M | 1.92M |
| Gross Profit | 315.25K | 6.79M | -5.09M | -1.98M | -2.86M | -4.42M |
| EBITDA | -3.46M | -41.97M | -22.27M | -5.53M | -9.00M | -6.61M |
| Net Income | -42.44M | -42.56M | -22.73M | -17.36M | -9.46M | -6.93M |
Balance Sheet | ||||||
| Total Assets | 224.76M | 98.96M | 141.56M | 152.20M | 54.12M | 24.04M |
| Cash, Cash Equivalents and Short-Term Investments | 202.41M | 81.96M | 117.00M | 140.74M | 46.53M | 19.90M |
| Total Debt | 1.24M | 910.20K | 1.18M | 772.14K | 982.50K | 38.40K |
| Total Liabilities | 7.37M | 8.01M | 9.62M | 3.51M | 3.57M | 1.97M |
| Stockholders Equity | 217.39M | 90.95M | 131.94M | 148.69M | 50.55M | 22.07M |
Cash Flow | ||||||
| Free Cash Flow | 8.32M | 2.86M | 5.85M | -2.43M | 287.28K | -4.96M |
| Operating Cash Flow | 8.41M | 3.02M | 6.14M | -2.34M | 412.64K | -4.78M |
| Investing Cash Flow | -164.37M | -2.61M | 7.56M | -114.40M | -40.06M | 9.79M |
| Financing Cash Flow | 143.61M | 403.06K | 2.34M | 114.55M | 38.20M | -199.34K |
Silex Systems Limited Technical Analysis
Negative
5.29
Price Trends
6.41
Negative
7.36
Negative
6.29
Negative
Market Momentum
-0.39
Negative
41.56
Neutral
66.05
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:SLX, the sentiment is Negative. The current price of 5.29 is below the 20-day moving average (MA) of 5.65, below the 50-day MA of 6.41, and below the 200-day MA of 6.29, indicating a bearish trend. The MACD of -0.39 indicates Negative momentum. The RSI at 41.56 is Neutral, neither overbought nor oversold. The STOCH value of 66.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:SLX.
Silex Systems Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | AU$883.15M | 11.05 | 42.94% | 10.16% | 25.67% | 744.90% | |
68 Neutral | AU$408.89M | 7.43 | 8.20% | ― | 1.06% | -30.96% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | AU$413.43M | 13.57 | 4.13% | ― | 0.40% | -280.65% | |
49 Neutral | AU$805.86M | -8.87 | -57.61% | ― | 333.23% | 10.83% | |
42 Neutral | AU$18.86M | -2.74 | -19.15% | ― | ― | -1034.67% | |
41 Neutral | AU$1.48B | -32.20 | -27.53% | ― | 5.81% | -86.09% |
* Technology Sector Average
AU:SLX
Silex Systems Limited
5.30
1.53
40.58%
AU:WIN
Widgie Nickel Limited
0.02
<0.01
10.00%
AU:BVS
Bravura Solutions Limited
1.97
-0.11
-5.42%
AU:TYR
Tyro Payments Ltd.
0.77
0.00
0.00%
AU:WBT
Weebit Nano Ltd.
3.82
1.77
86.34%
AU:NXL
Nuix Ltd.
1.24
-1.97
-61.41%
Silex Systems Limited Corporate Events
Silex-Backed GLE Wins US$98.9m Incentive Deal for Paducah Enrichment Plant
Mar 26, 2026
Global Laser Enrichment, the exclusive licensee of Silex Systems’ laser uranium enrichment technology, has secured preliminary approval for up to US$98.9 million in performance-based tax and economic incentives from the Commonwealth of Kentu...
Silex Systems Options Lapse, Slightly Streamlining Capital Structure
Mar 24, 2026
Silex Systems Limited has announced the cessation of 7,500 SLXAJ options, which expired on 23 March 2026 without being exercised. The expiry slightly reduces the company’s pool of potential dilutive securities, marginally simplifying its cap...
Silex Systems Seeks ASX Quotation for New Share Issuance
Mar 24, 2026
Silex Systems Limited has applied for quotation on the ASX of 63,800 ordinary fully paid shares, to be issued on March 24, 2026. The new securities arise from the exercise or conversion of existing options or other convertible instruments, margina...
BNY Mellon Group Ceases to Be Substantial Holder in Silex Systems
Mar 15, 2026
The Bank of New York Mellon Corporation and its related entities have notified Silex Systems that they have ceased to be substantial holders in the company as of 12 March 2026. This change in substantial holding indicates that a major institutiona...
BNY Mellon Group Ceases to Be Substantial Holder in Silex Systems
Mar 4, 2026
The Bank of New York Mellon Corporation and its related group entities have notified Silex Systems Limited that they have ceased to be substantial shareholders in the company as of 3 March 2026. This change in holding, disclosed under Australian s...
Silex Systems Seeks ASX Quotation for 261,700 New Ordinary Shares
Mar 4, 2026
Silex Systems Limited has applied for quotation on the ASX of 261,700 new ordinary fully paid shares, issued on March 4, 2026. The additional securities result from the exercise or conversion of existing options or other convertible instruments, m...
Silex Systems Director Trims Stake in $6.63‑a‑Share Block Trade
Mar 2, 2026
Silex Systems director Christopher Wilks has reduced his shareholding through an on‑market institutional broker sale of 850,000 fully paid ordinary shares at $6.63 per share, executed on 27 February 2026. Following the transaction, Wilks hol...
Silex Director Trims Stake but Retains Significant Holding
Mar 2, 2026
Silex Systems has disclosed a change in the interests of director Michael Goldsworthy, who holds his stake both directly and indirectly through Majenta Holdings Pty Ltd. The filing outlines his substantial existing shareholding, including ordinary...
Silex Systems Director Cuts Stake but Retains Significant Holding
Mar 2, 2026
Silex Systems has disclosed a change in the shareholding of director Craig Roy, who conducted an on-market sale of 129,507 fully paid ordinary shares at an average price of $6.896 per share. Following the transaction, Roy’s direct holding in...
Silex Hits Key Readiness Milestone as U.S. Laser Enrichment Plans Advance
Feb 24, 2026
Silex Systems reported that its SILEX laser uranium enrichment technology, developed with Global Laser Enrichment, has reached Technology Readiness Level 6 following large-scale demonstration at GLE’s integrated pilot plant in Wilmington, No...
Silex Systems Boosts Cash Reserves as Revenue Doubles but Loss Persists
Feb 24, 2026
Silex Systems reported a sharp improvement in liquidity for the half-year ended 31 December 2025, with cash, term deposits and dual currency term deposits rising 150.4% to about $201.7 million from June 2025. Revenue from ordinary activities more ...
Silex Systems to Release 395,507 Shares From Voluntary Escrow
Feb 10, 2026
Silex Systems Limited has announced that 395,507 fully paid ordinary shares will be released from voluntary escrow on 27 February 2026. The move increases the number of tradeable shares on the market and may enhance liquidity for existing and pros...
Silex-Backed GLE Wins US DOE Innovation Funding for Laser Uranium Enrichment
Jan 5, 2026
Global Laser Enrichment, the exclusive licensee of Silex Systems’ SILEX uranium enrichment technology, has been selected by the U.S. Department of Energy for an Innovative Technology Award of up to US$28 million to advance next-generation la...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.